Glaucoma Trial, Recruiting (NCT05726058)

Glaucoma Trial, Recruiting NCT05726058 Sponsor: University of Maryland, Baltimore Condition: Glaucoma

Printed from Voxsanity (voxsanity.com.au) — NCT05726058 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Glaucoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older who have vision in both eyes
People who are able to give their informed consent to participate
People who are either healthy volunteers, have been referred for a glaucoma assessment, or have been diagnosed with moderate to severe glaucoma in at least one eye

Who may not be able to join:

People who have a significant clouding or scarring of the eye, such as a visually significant cataract or corneal scar
People who have had eye surgery in the past, other than straightforward cataract removal, certain laser eye pressure treatments (ALT or SLT), or a YAG capsulotomy procedure
People who have had a prior eye disease other than glaucoma
People who have naturally very narrow drainage angles in the eye, or who have previously had a bad reaction to the eye drops Tropicamide or the dye fluorescein
People with a glasses or contact lens prescription stronger than 15 diopters (a measure of how much correction the eye needs)
People who are currently pregnant or breastfeeding
People who have diabetes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Grace Forbes, MS, University of Maryland, Baltimore

Phone: (410) 328-5929

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05726058

Sponsor: University of Maryland, Baltimore

Phase: Not Applicable

Status: Recruiting

Condition: Glaucoma

Trial contact: (410) 328-5929

More information: https://clinicaltrials.gov/study/NCT05726058

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older who have vision in both eyes
People who are able to give their informed consent to participate
People who are either healthy volunteers, have been referred for a glaucoma assessment, or have been diagnosed with moderate to severe glaucoma in at least one eye

Who may not be able to join:

People who have a significant clouding or scarring of the eye, such as a visually significant cataract or corneal scar
People who have had eye surgery in the past, other than straightforward cataract removal, certain laser eye pressure treatments (ALT or SLT), or a YAG capsulotomy procedure
People who have had a prior eye disease other than glaucoma
People who have naturally very narrow drainage angles in the eye, or who have previously had a bad reaction to the eye drops Tropicamide or the dye fluorescein
People with a glasses or contact lens prescription stronger than 15 diopters (a measure of how much correction the eye needs)
People who are currently pregnant or breastfeeding
People who have diabetes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Maryland, Baltimore

Registry

ClinicalTrials.gov

Start date

30 March 2023

Est. completion

31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Blood flow velocity measure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov